COMMUNIQUÉS West-GlobeNewswire

CARBIOS et Hündgen concluent un accord d’approvisionnement pour la première usine de biorecyclage du PET au monde
02/05/2024
CARBIOS et Hündgen concluent un accord d’approvisionnement pour la première usine de biorecyclage du PET au monde A partir de fin 2026, Hündgen fournira 15kt/an de paillettes de PET post-consommation à la première usine [...]
Three Pivotal Drug Policy Organizations Hold Media Briefing/Q&A on DEA Rescheduling of Cannabis
01/05/2024
Executives from MAPS, NORML, and MPP to Celebrate DEA Rescheduling of Cannabis to Schedule III Drug and Debunk Myths WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- What: The Multidisciplinary Association for Psychedelic [...]
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2024
RESEARCH TRIANGLE PARK, N.C., May 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 2,100 [...]
Pennant Acquires Senior Living Community in Idaho
01/05/2024
EAGLE, Idaho, May 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2024
NEW YORK and SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule [...]
Pennant Acquires Utah Home Health and Hospice Provider
01/05/2024
EAGLE, Idaho, May 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced [...]
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
01/05/2024
FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing [...]
HiberCell Announces First Patient Dosed in Clinical Collaboration with Merck, Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in patients with advanced ccRCC
01/05/2024
BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, is pleased to announce the dosing of the [...]
SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results
01/05/2024
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a [...]
Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
01/05/2024
IRVINE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]
Emergent BioSolutions Reports First Quarter 2024 Financial Results
01/05/2024
First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance range First Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 million Updates FY 2024 guidance GAITHERSBURG, Md., May 01, [...]
Teladoc Health Is Providing Free Virtual Health Care Services to Oklahoma Residents Impacted by Tornadoes
01/05/2024
PURCHASE, NY, May 01, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to Oklahoma residents, first [...]
STERIS Announces Dividend of $0.52 per share
01/05/2024
DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is [...]
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
01/05/2024
BAUDETTE, Minn., May 01, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, [...]
Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
01/05/2024
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its first quarter 2024 financial results will be released after market close on Thursday, [...]
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
01/05/2024
MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical [...]
DLH Reports Fiscal 2024 Second Quarter Results
01/05/2024
Revenue Grows and Backlog Strengthens as Debt Reduction Continues ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and [...]
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
01/05/2024
Tinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular [...]
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/05/2024
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of covalent [...]

Pages